Skip to main content

Table 2 Predictors for variceal rebleeding

From: Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis

Variables

Rating

Univariate analysis for variceal bleeding

Univariate analysis for gastric variceal bleeding

Hazard ratio

95% CI

P value

Hazard ratio

95% CI

P value

Age

Years

0.997

0.969–1.025

0.814

1.000

0.970–1.032

0.992

Sex

0 = women; 1 = men

1.384

0.678–2.825

0.373

1.447

0.654–3.198

0.362

Diabetes

0 = no; 1 = yes

1.019

0.524–1.982

0.955

1.060

0.513–2.192

0.874

Etiology

0 = other; 1 = alcohol

1.195

0.644–2.219

0.573

1.242

0.630–2.450

0.531

Size of esophageal varices

0 = F0, F1; 1 = F2, F3

1.131

0.595–2.149

0.707

1.091

0.536–2.222

0.809

Hemoglobin

g/dL

0.977

0.869–1098

0.695

0.976

0.859–1.109

0.707

Platelet count

× 109/L

1.003

0.998–1.009

0.261

1.002

0.995–1.008

0.628

INR

 

0.732

0.233–2.301

0.593

0.944

0.348–2.563

0.910

Alanine aminotransferase

IU/L

1.002

0.995–1.008

0.642

1.002

0.994–1.009

0.679

Total bilirubin

mg/dL

1.017

0.942–1.098

0.662

1.026

0.948–1.110

0.520

Serum albumin

g/dL

1.106

0.590–2.073

0.754

0.808

0.402–1.627

0.551

MELD score

 

1.025

0.952–1.103

0.515

1.049

0.973–1.131

0.213

Type of varices

0 = GOV2; 1 = IGV1

1.190

0.6041–2.207

0.581

1.008

0.511–1.990

0.981

Type of treatment

0 = RTO; 1 = EVO

1.557

0.816–2.970

0.179

3.132

1.408–6.970

0.005

Beta-blocker

0 = no; 1 = yes

0.879

0.430–1.798

0.724

0.994

0.463–2.136

0.988

Post EVL

0 = no; 1 = yes

0.652

0.324–1.310

0.229

0.760

0.360–1.606

0.473

  1. IGV1 isolated gastric varices type 1, GOV2 gastroesophageal varices type 2, INR international normalized ratio, MELD model for end-stage liver disease, EVO endoscopic variceal obturation, RTO retrograde transvenous obliteration, EVL endoscopic variceal ligation